A Survey on Diagnosis and Prognosis of Prenatal Asphyxia based on
Antioxidant Oxidant Balance: Evidence from a Systematic Review and
Meta-Analysis
Authors: Hassan Boskabadi , Samin Amirkhani , Loghmani Tahereh , Maryam Zakerihamidi 
Published: January 2024

Introduction:

The mechanism of occurrence and complications of asphyxia change in
the treatment process and the future prognosis of newborns. One of the discussed mechanisms is
the disruption of oxidants to anti-oxidants balance. Therefore, the current study was conducted
aiming to systematically review and conduct a meta-analysis on the diagnosis and prognosis of
prenatal asphyxia based on oxidant-antioxidant balance

Methods:

A comprehensive electronic search was conducted using PubMed, Cochrane Library,
Scopus, and Web of Science databases, up to February 2023 to identify relevant studies examining the association between Prooxidant anti-oxidant balance (PAB) and Malondialdehyde 1 levels
with the risk of prenatal asphyxia. Only English studies were incorporated. The search terms used
included Asphyxia, Diagnosis, Prognosis, Newborns, Prenatal, Oxidant antioxidant balance, and
oxidative stress. A total of 13 studies were retrieved. Data regarding the standard mean difference
(SMD) were collected, and a pooled SMD with 95%CI was calculated using a random-effect model to determine the strength of the relationship. Furthermore, the risk of publication bias was assessed through funnel plot and Egger’s linear regression tests. Inclusion criteria was 1) The
studies conducted on neonates, diagnosis and outcomes of prenatal asphyxia, oxidants and antioxidants were included. Research conducted on adults or on animals or review articles, and articles in
which only their abstracts were available were excluded. The quality of the reported studies was also assessed.

Results:

Out of 980 searched articles, 13 articles (10 prospective articles and 3 cross-sectional articles) were studied. An increase in antioxidant enzymes (Glutathione peroxidase (GSH-Px), catalase (CAT) and Plasma superoxide dismutase (SOD)) cannot be dealt with excessive oxidants produced in the body (Plasma and cerebrospinal fluid levels of Malondialdehyde (MDA), free radical
products (F8-isoprostane and MDA), saturated fatty acids and % CoQ-10). Prooxidant anti-oxidant balance (PAB) levels among neonates who had asphyxia were announced to be two times
higher than normal newborns. PAB values in neonates with asphyxia, who had adverse prognosis,
were about three times higher than those with favorable prognosis. The sensitivity of PAB in predicting the prognosis of neonates with asphyxia was reported 83- 89% and its specificity was 71-
92%. The pooled SMD analysis revealed a significant association between PAB and MDA levels
with the risk of prenatal asphyxia both overall (SMD = 1.447, 95%CI: 0.961-1.934, P < 0.001), as
well as separately in subgroups of PAB (SMD = 1.134, 95%CI: 0.623-1.644, P < 0.001) and
MDA (SMD = 1.910, 95%CI: 0.916-2.903, P < 0.001).

Conclusion:

Our meta-analysis findings revealed the potential of evaluating antioxidant enzymes
and oxidant agents, as well as assessing the balance between them (PAB), in diagnosing and predicting the prognosis of neonatal asphyxia. The limitations of the present study included not having access to all related complete articles, lack of quality and usability in reports of some articles,
and the different diagnostic methods of prenatal asphyxia in different studies.